#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.MedicalEntity|DCT|MedicalEntity
#T_RL=webanno.custom.TLINK|TLINK|BT_webanno.custom.MedicalEntity


#Text=18.04.2023:
#Text=Kontroll hypothyreose.
1-1	0-10	18.04.2023	_	_	_	_	
1-2	10-11	:	_	_	_	_	
1-3	12-20	Kontroll	OVERLAP	TREATMENT	_	_	
1-4	21-33	hypothyreose	_	_	_	_	
1-5	33-34	.	_	_	_	_	

#Text=Fortsatt symptomatisk med fatigue.
2-1	35-43	Fortsatt	_	_	_	_	
2-2	44-56	symptomatisk	OVERLAP[1]	CONDITION[1]	_	_	
2-3	57-60	med	OVERLAP[1]	CONDITION[1]	_	_	
2-4	61-68	fatigue	OVERLAP[1]	CONDITION[1]	_	_	
2-5	68-69	.	_	_	_	_	

#Text=TSH 8.4, fT4 10.1.
3-1	70-73	TSH	_	_	_	_	
3-2	74-77	8.4	_	_	_	_	
3-3	77-78	,	_	_	_	_	
3-4	79-82	fT4	_	_	_	_	
3-5	83-87	10.1	_	_	_	_	
3-6	87-88	.	_	_	_	_	

#Text=Øker Levaxin til 75µg x1.
4-1	89-93	Øker	_	_	_	_	
4-2	94-101	Levaxin	AFTER[2]	TREATMENT[2]	_	_	
4-3	102-105	til	AFTER[2]	TREATMENT[2]	_	_	
4-4	106-110	75µg	AFTER[2]	TREATMENT[2]	_	_	
4-5	111-113	x1	_	_	_	_	
4-6	113-114	.	_	_	_	_	

#Text=Supplerende blodprøver viser normal jernstatus og B12.
5-1	115-126	Supplerende	_	_	_	_	
5-2	127-137	blodprøver	OVERLAP	CONDITION	_	_	
5-3	138-143	viser	_	_	_	_	
5-4	144-150	normal	OVERLAP[3]	CONDITION[3]	BEFORE	5-2[0_3]	
5-5	151-161	jernstatus	OVERLAP[3]	CONDITION[3]	_	_	
5-6	162-164	og	OVERLAP[3]	CONDITION[3]	_	_	
5-7	165-168	B12	OVERLAP[3]	CONDITION[3]	_	_	
5-8	168-169	.	_	_	_	_	

#Text=Avtaler ny kontroll om 8 uker.
6-1	170-177	Avtaler	_	_	_	_	
6-2	178-180	ny	_	_	_	_	
6-3	181-189	kontroll	AFTER	TREATMENT	BEFORE	4-2[2_0]	
6-4	190-192	om	_	_	_	_	
6-5	193-194	8	_	_	_	_	
6-6	195-199	uker	_	_	_	_	
6-7	199-200	.	_	_	_	_	
